Questions

392. Deputy Colm Burke asked the Minister for Health whether the forthcoming National Cardiovascular Health Strategy will be developed as a comprehensive National Cardiovascular Health Strategy that builds upon the recommendations of the National Review of Adult Specialist Cardiac Services while also aligning with the objectives of the European Commission's Safe Hearts Plan and the forthcoming EU Council Recommendati…

565. Deputy Colm Burke asked the Minister for Health to provide an update on a new cardiovascular strategy; the expected timeline for its publication; and if she will make a statement on the matter. [13452/26]

566. Deputy Colm Burke asked the Minister for Health whether a new national cardiovascular strategy will be produced; if it will include nationwide screening and early detection of structural heart disease, cardiovascular disease and cardiovascular risk assessment programmes; how Ireland will align with OECD and EU recommendations (details supplied); if dedicated resources will be allocated to prevention and early de…

663. Deputy Colm Burke asked the Minister for Health the aspects of the National Strategy for Accelerating Genetics and Genomic Medicine that will be progressed in 2026; the funding that will be required to do so; and if she will make a statement on the matter. [13896/26]

2033. Deputy Colm Burke asked the Minister for Health how she plans to prioritise and implement the EU cardiovascular disease health plan in Ireland and channel EU funds to support this work; and if she will make a statement on the matter. [73853/25]

500. Deputy Colm Burke asked the Minister for Health when the evaluation process for the current National Cancer Strategy will commence; the person in her Department is responsible for this review; and if she will make a statement on the matter. [66865/25]

501. Deputy Colm Burke asked the Minister for Health when the consultation process for the next National Cancer Strategy will begin; the stakeholders that will be involved in the development of the next strategy; the person in her Department who is responsible for this; and if she will make a statement on the matter. [66866/25]

2160. Deputy Colm Burke asked the Minister for Health further to Parliamentary Question No. 322 of 2 April 2025, the number of cancer patients approved under the treatment abroad scheme between the years 2020 to 2024 received funding to cover their economic air or sea fares under the scheme; the number of companion/carers were approved for funding for economic air or sea fares under the scheme, in tabular form; and i…

320. Deputy Colm Burke asked the Minister for Health the financial supports for travel expenses, and other related costs, available to patients, or their travelling companion, under the treatment abroad scheme; and if she will make a statement on the matter. [16142/25]

321. Deputy Colm Burke asked the Minister for Health to detail the circumstances where air or sea travel fares are covered for patients, or a travelling companion, under the treatment abroad scheme; and if she will make a statement on the matter. [16143/25]

322. Deputy Colm Burke asked the Minister for Health the number of recipients of the HSE treatment abroad scheme aged 0 to 24 years of age who have travelled outside of Ireland for specialised cancer treatment not available in Ireland in 2020, 2021, 2022, 2023 and 2024, in tabular form; including the total number of applicants to the scheme seeking to avail of specialised cancer treatment for each of those years, in …

323. Deputy Colm Burke asked the Minister for Health the number of recipients of the HSE treatment abroad scheme aged 25 plus years of age who have travelled outside of Ireland for specialised cancer treatment not available in Ireland in 2020, 2021, 2022, 2023 and 2024, in tabular form; including the total number of applicants to the scheme seeking to avail of specialised cancer treatment for each of those years, in …

334. Deputy Colm Burke asked the Minister for Health to provide an update on the "pause" of mesh for the surgical treatment of stress urinary incontinence that has been in place since July 2018; and if she will make a statement on the matter. [16230/25]

335. Deputy Colm Burke asked the Minister for Health the reason the pause on mid-urethral sling surgery has not been lifted even though national guidelines which were commissioned, endorsed and published by the HSE in January 2023, recommend that all women who need surgery for stress urinary incontinence should be offered this as an option alongside all other appropriate surgical operations; and if she will make a st…

336. Deputy Colm Burke asked the Minister for Health if the 19 recommendations made by the chief medical officer in his 2018 report "The use of Uro-Gynaecological mesh in surgical procedures" have been addressed; and if she will make a statement on the matter. [16232/25]

337. Deputy Colm Burke asked the Minister for Health if the National Mesh Oversight Group has produced the report it was commissioned to complete by the end of 2023; if so, when this report will be published; and if she will make a statement on the matter. [16233/25]

338. Deputy Colm Burke asked the Minister for Health if the current chief medical officer has provided an update on the pause of mesh for the surgical treatment of stress incontinence; and if she will make a statement on the matter. [16234/25]

342. Deputy Colm Burke asked the Minister for Health the reason why women with stress incontinence are not offered mid-urethral sling surgery as an option, despite the national clinical guidelines recommending that women have a choice of procedure and that the Assisted Decision-Making (Capacity) (Amendment) Act 2022, providing for their legal right to make informed decisions about their health; and if she will make a…